Acrylamide (AA) is a probable human carcinogen found in several foods. Little information is available regarding exposure of adolescents, a subgroup potentially consuming more AA-rich foods. We investigated the relationship between dietary AA intake and levels of biomarkers of exposure (urinary metabolites and hemoglobin adducts) in 195 non-smoking teenagers of Montreal Island aged 10-17 years. Dietary habits and personal characteristics were documented by questionnaire. AA and its metabolites were quantified in 12-h urine collections by LC-MS/MS. Hemoglobin adducts from 165 blood samples were also analyzed by LC-MS/MS. Most prevalent urinary metabolites were NACP and NACP-S, with respective geometric mean concentrations of 31.2 and 14.2 mmol/ mol creatinine. Geometric mean concentrations of AAVal and GAVal (hemoglobin adducts of AA and glycidamide (GA) with N-terminal valine residues) were 45.4 and 45.6 pmol/g globin, respectively. AA intake during the 2 days before urine collection was a significant predictor of NACP þ NACP-S urinary concentrations (Po0.0001). AA intakes during the month before blood collection (Po0.0001) and passive smoking (Po0.05) were associated with adduct levels. Levels of hemoglobin adducts were above biomonitoring equivalent values corresponding to a 1 Â 10 À 4 excess cancer risk, which may indicate the need to reduce AA exposure in the population.
INTRODUCTION
Acrylamide (AA), or 2-propenamide, is a colorless and odorless vinylic compound, which can be easily polymerized to polyacrylamide. 1 This polymer is used in many chemical technologies as a binding, thickening, coagulating or flocculating agent. Individuals may be exposed to AA in the workplace and in the general environment, through the diet and tobacco smoking. 2 Concerns for widespread exposure emerged when Swedish scientists found detectable concentrations of AA in several heated foods, particularly in fried, roasted or baked starch-based goods. 3 Subsequent studies identified the mechanism of formation of AA, a reaction between asparagine and reducing sugar in food processed at high temperature (120-180 1C). 4, 5 The neurotoxic potential of AA has been known for over 40 years following studies in occupationally exposed workers. 6 Subsequently, experiments in rodents treated with AA revealed the carcinogenic potential of this chemical. 7, 8 Several epidemiologic studies have investigated the possible link between dietary acrylamide intake and increased cancer risk, but results have been inconsistent. Initial cohort studies conducted by Mucci et al. 9, 10, 11, 12 and Pelucchi et al. 13 did not reveal any association between AA exposure and cancer risk. However, Hogervorst et al. 14 reported an elevated risk of endometrial and ovarian cancer, but not breast cancer, associated with dietary AA intake in a prospective study of postmenopausal women. Similar associations were observed in a study involving younger women aged 30-55 years. 15 Olesen et al. 16 noted a positive association between hemoglobin adducts levels and breast cancer risk in a case-control study of postmenopausal women. Biomarkers of AA exposure were only measured in the study of Olesen et al.; 16 dietary questionnaires were used in the other studies, which may have led to exposure misclassification.
Dietary AA exposure is not evenly distributed in the general population. Children and teenagers have been reported to exhibit a 2-to 3-fold higher AA intake than adults, 17 first, because of their higher food consumption per kg of body weight and, second, because they are considered to consume more AA-rich foods (e.g., French fries and potato chips) than other population subgroups. 18 Heudorf et al. 19 reported a positive association between French fries consumption and urinary AA metabolites levels in 5-to 6-yearold German children. Vesper et al. 20 did not observe any significant difference in adduct levels between teenagers and adults, whereas Hartmann et al. 21 observed higher biomarker levels (urine metabolites and hemoglobin adducts) in a teenager subgroup compared with adults. To our knowledge, only one small study involving 11 teenagers aged 11-18 years used both urinary and blood biomarkers to characterize AA exposure. 21 Hence, there is a need to better characterize internal exposure to AA in teenagers using different biomarkers of exposure.
We previously estimated the distribution of dietary intakes of acrylamide in a group of non-smoking adolescents living in Montreal, Canada. 22 Here we report results of biological measurements of exposure to AA in these individuals. We also tested correlations between exposure biomarker levels and both 1 short-term (last 48 h) or long-term (last month) dietary AA intake estimates reported in Normandin et al. 22 
MATERIALS AND METHODS

Study Population and Recruitment of Participants
Recruitment and data collection took place between October 2009 and February 2010. Adolescents were randomly recruited either by e-mail or phone from a list of names, addresses and phone numbers of residents of the Island of Montreal (Province of Quebec, Canada). For phone recruitment, agents contacted parents who were residents of Montreal for a preliminary assessment of the eligibility of their teenagers and to explain the research project. If one teenager was deemed eligible, the parental authority was asked to provide preliminary consent for the potential enrolment of his or her teenager(s) and for permission to speak to them. Up to two teenagers could participate per household and the adolescents whose birthday was closest to the date of telephone contact were first solicited. After explaining the project to the teenagers and upon consent to participate, they were asked to complete a telephone survey designed to further verify their eligibility, collect sociodemographic data including gender, ethnicity, education, school (public or private), language spoken at home and language spoken with friends. For e-mail recruitment, parents interested in having their adolescent participate in the study were invited to complete the same questionnaire but online to verify eligibility and sociodemographic data, with their teenager. Smokers (n ¼ 11) and participants previously diagnosed with cancer (n ¼ 1) or liver/kidney diseases (n ¼ 2) were excluded from the study. A total of 200 adolescents aged 10 to 17 years were recruited in our study. Four participants were excluded because urinary cotinine analysis revealed a level higher than 150 mg/l, indicative of active smoking. 23 One participant did not provide any urine sample. Therefore, the final sample size for this study was 195 participants.
Data Collection and Biological Sample Collection, Processing and Storage
A research nurse met with each participant accompanied by one parent in their home to (1) explain the project in detail; (2) obtain written consents from the participant and the parent; (3) provide a bottle and instructions for urine collection; (4) collect blood samples; and (5) provide and explain how to fill the food diary (with the help of food models of standardized portions) and self-administered questionnaires.
Participants collected their urine over a E12-h period, hence from 1800 h to at least 0600 h the next day, including the first void of the day. A 1500-ml polyethylene Nalgene bottle was provided to each participant for urine collection and temporary storage in the home refrigerator. They were picked up within 24 h by a staff member and brought to the laboratory of the University of Montreal for aliquoting. Aliquots for urinary cotinine analysis were sent to the Institute for Work and Health in Lausanne, Switzerland, whereas the aliquots for urinary metabolite determination were sent to the toxicology laboratory of the Institut National de santé publique du Qué bec (INSPQ, Quebec, QC, Canada).
Blood samples were collected in 10-ml plastic Vacutainers containing potassium N-NACP-S) were synthesized by the Organic Synthesis Service at CHUQ Research Center (Quebec, QC, Canada). Isotopically labeled phenythiohydantoin derivatives of N-(2-carbamoylethyl)valine (AAVal) and N-(2-carbamoyl-2-hydroxyethyl)valine (GAVal)-13 C 5 -AAValPTH and 13 C 5 -GAValPTH-were synthesized at RTI according to the method described by Fennell et al. 24 
Analysis of Acrylamide and Metabolites in Urine Samples
Acrylamide and its main metabolites, GA, CP, NACP, GAMA2, GAMA3 and NACP-S, were quantified in urine samples by LC-MS/MS using a method adapted from Fennell et al. 25, 26 Urine samples were thawed in the refrigerator, vortex mixed and aliquots of 100 ml were placed in 500 ml microtubes. A total volume of 10 ml internal standard solution ( 13 C 3 -AA 1 mg/ml, 13 C 3 -GA 5 mg/ml, 13 N-NACP-S 2 mg/ml) was added to each sample, which was subsequently vortexed and centrifuged at 21,000 Â g for 5 min at 4 1C. Then, 20 ml of the supernatant was transferred into a LC vial containing 80 ml of a 0.08% acetic acid solution and the resulting solution was vortexed.
Analysis was conducted using an Acquity UPLC system (Waters, Milford, MA, USA) coupled to a Waters Xevo TQ MS/MS. Chromatography was performed on a Waters Atlantis dC18 column (100 mm Â 4.6 mm, 3 mm) and compounds were eluted with a gradient constituted of 0.08% acetic acid in water (mobile phase A) and acetonitrile (mobile phase B) at a flow rate of 500 ml/min, over a 15-min period. The gradient started with 100% mobile phase A for 7 min, lowered to 91% A for 4 min. A 1 min wash was performed by increasing acetonitrile to 99%, before returning to the original conditions. The ionization source was operated in electrospray positive mode. The mass transitions used for quantification were: AA, m/z 72.0-55.1; Quantification of AA and its metabolites was performed with a calibration curve using the analyte to internal standard peak area ratio. Data were integrated using MassLynx 4.1 (Waters) and data treatment was performed with the Starlims software (Abbott Laboratories, Abbott Park, IL, USA). Two home-made reference materials (RMs) in urine were used for quality control, a low-level RM (AA, 120 mg/l; CP, 40 mg/l; GA, 600 mg/l; GAMA2, 320 mg/l; GAMA3, 80 mg/l; NACP, 200 mg/l; NACP-S, 400 mg/l) and a high-level RM (four times the concentrations of the low RM). We inserted alternately a low and a high RM after each analytical batch of 10 unknown samples. Supplementary Table S1 of Supplementary Material lists the elements of performance for this LC-MS/MS method.
Interlaboratory Comparison of Urinary Metabolite Concentrations
Because of the lack of reference materials for laboratory performance evaluation, a series of urine samples (n ¼ 56) were analyzed both at the INSPQ toxicology laboratory and at RTI International. In the latter laboratory, urine samples were processed for analysis as described in Fennell et al. 26 with minor modifications. Samples were thawed on ice and 80 ml was taken for analysis. A total volume of 10 ml of a stock internal standard solution ( 13 C 3 -AA and d 4 -NACP) at 2 mg/ml was added to each urine sample. In addition, 20 ml of water was added. Each sample was vortexed and centrifuged at 14,000 r.p.m. for 2 min. Then, 10 ml of the sample was mixed with 90 ml of water, vortexed and centrifuged. The sample was transferred to a low-volume insert for LC/MS analysis. Analysis was conducted using an Agilent 1100 HPLC system coupled to a AB Sciex API4000 MS/MS with a Turboionspray interface. Chromatography was conducted on a Waters Atlantis dC18 column (250 Â 4.6 mm, 5 mm), with 0.1% formic acid in water and acetonitrile as mobile phases, at a flow rate of 1000 ml/min. The first 25 min of the elution was conducted with 0.1% formic acid in water. At 25 min, the acetonitrile was increased to 95% and held for 5 min until returning to original conditions. Analysis was conducted using two periods. The first period was used to quantify acrylamide, GAMA2, GAMA3 and NACP-S, and was performed in positive polarity in 16 min. At 16 min the polarity was changed to negative to quantify NACP. The elution of compounds was monitored by multiple reaction monitoring (MRM) in the positive ion mode for the following ions: AA, m/z 72-55; GAMA2, m/z 251-162; GAMA3: m/z 251-146; NACP-S, m/z 251-162; 13 C 3 -AA, m/z 75-58. The elution of compounds was monitored by MRM in the negative ion mode for the following ions: NACP, m/z 233-104; d4-NACP, m/z 237-108. Quantification was conducted using the analyte to internal standard peak area ratio. Very good correlations were obtained between results from the two laboratories for NACP and NACP-S (see Supplementary Figure S1 in Supplementary Materials).
Analysis of Hemoglobin Adducts
A LC-MS/MS method was used to measure AAVal and GAVal, which are respectively formed by the reaction of AA and GA with the N-terminal valine residue of hemoglobin. Globin was isolated from washed red cells as described by Mowrer et al. 27 In short, lysed red blood cells were mixed with 50 mM HCl in 2-propanol to precipitate heme. After centrifugation at 3000 Â g, the supernatant was mixed with ethyl acetate and the resulting precipitate washed with n-pentane. Globin was dried under vacuum, weighed into aliquots and stored at À 20 1C until analysis. Globin samples were processed as described by Fennell et al. 25 Samples were derivatized with phenylisothiocyanate in formamide to form adduct phenylthiohydantoin derivatives. Internal standards of 13 C 5 -AAValPTH and 13 C 5 -GAValPTH were added and the samples were extracted using a Waters Oasis HLB 3 cc (60 mg) extraction cartridge. The samples were eluted with methanol, dried and reconstituted in 100 ml of 50:50 MeOH/H 2 O (containing 0.1% formic acid). Analysis was conducted using an Agilent 1200 HPLC system coupled to an AB Sciex API 5000 MS/MS with a Turboionspray interface. Chromatography was performed on a Phenomenex Luna Phenyl-Hexyl Column (50 Â 2 mm, 3 mm) eluted with 0.1% acetic acid in water and methanol at a flow rate of 400 ml/min, with a gradient of 40-70% methanol in 3 min. Methanol was held at 70% for 2 min before returning to original conditions. The elution of adducts was monitored by MRM in the negative ion mode for the following ions: AAVal-PTH, m/z 304-233; GAVal-PTH, m/z 320-233; 13 C 5-AAValPTH, m/z 309-238; 13 C 5-GAValPTH: m/z 325-238. Quantification of AAVal and GAVal was conducted using the analyte to internal standard peak area ratio, with a calibration curve generated using AAVal-leu-anilide or GAValleu-anilide.
Urinary Cotinine Analysis
Cotinine concentration in urine samples was measured at Institute for Work and Health (Lausanne, Switzerland) using a standard validated LC-MS/MS method.
Assessment of Dietary Acrylamide Intake
Estimations of recent and long-term dietary acrylamide intakes were published in Normandin et al. 22 Briefly, a food diary was filled by each participant to document the amounts of acrylamide-rich foods consumed over a 2-day period preceding urine collection (breakfast cereals, toasted bread, deep-fried French fries, oven-baked French fries, potato chips, corn chips, popcorn, pretzels, roasted almonds, crackers, cookies, chocolate chips, black olives, brewed coffee and prune juice). Participants also completed a pretested food frequency questionnaire (FFQ) to document the consumption of the same food items over the last month. Models of standardized portions were provided to help in estimating the weight of foods and volume of drinks consumed. An extensive database was assembled that comprised acrylamide concentrations measured by LC-MS/ MS 22, 28 in samples of the most frequent foods consumed by our participants. If a specific food item was not analyzed, we used concentrations measured by the same laboratory during previous Canadian surveys and in some cases US data. 29, 30 For each participant, daily amounts in grams of each food item (average daily consumption based on the 2-day diary) were thus multiplied by corresponding measured mean concentration of acrylamide (ng/g). The contributions from all foods were then summed and the resulting individual intake was divided by the body weight (bw) of the participant to yield an acrylamide dose expressed in mg/ kg bw/day for each participant. A distribution of acrylamide intake was thus obtained for the entire group of participants. A similar calculation was performed to yield a daily acrylamide dose over the last month for each participant, based on daily amounts of the same food items reported to be consumed during the last month in the FFQ.
Lifestyle Questionnaire
Participants completed a short questionnaire on their lifestyle habits, which covered second-hand smoke exposure, alcohol consumption and the use of personal hygiene products, which are potential sources of acrylamide exposure. The participants were also asked to provide their current body weight.
Statistical Analysis
Normality of distributions was tested with the Shapiro-Wilk test. Distributions of all urinary metabolites and hemoglobin adducts were log-normal. Descriptive statistics for these analytes included the geometric mean and 95% confidence interval (CI), min, max and percentiles. Concentrations below the limit of detection (LOD) of the analytical method were replaced by a value equal to half of the LOD. Spearman's correlations were carried out to test the relation between dietary AA intakes (mg/kg bw/day) and biomarker concentrations. Pearson's correlations were used to test the correlations among biomarkers of exposure (log-transformed values). Multivariate linear regression analyses were conducted to control for possible confounding factors of the relationship between dietary AA intake and biomarkers of exposure. For the urinary biomarker analysis, the dependent variable was the sum of concentrations of the two main metabolites, NACP and NACP-S (mmol/l). The independent variable was the mean dietary AA (mg/kg bw/day) during the 2 days or during the month preceding urine sampling. For hemoglobin adduct analysis, the dependent variable was the sum of AAVal and GAVal adduct levels (pmol/g globin), and the independent variable was average daily AA dietary intake during the month preceding blood sampling. Potential confounding factors were age (continuous), gender, second-hand smoke (none, low or high exposure), alcohol intake in the last month (yes or no), parents education (elementary or high school, college, university), country of origin (Canada or other) and school (public or private). Before multivariate analyses, bivariate analyses were conducted to evaluate associations between potentially confounding factors and exposure biomarkers. Factors associated with a P-value of o0.20 were first selected. Then, the factor with the weakest P-value was inserted in the multivariate linear regression model and was kept if it caused the b-coefficient of the relation between AA intake and the biomarker of exposure to vary by more than 10%. The same procedure was applied for all factors initially selected. Urinary creatinine concentration was forced in all urinary biomarker models. Final multivariate models were checked for multicollinearity problems and for normality of residuals. The SAS version 9 software (SAS Institute, Cary, NC, USA) was used to perform statistical analyses. The statistical significance level was set at 0.05.
Ethics and Confidentiality
The research project was approved by research human ethics committee of the Faculty of Medicine of University of Montreal (CERFM) and Health Canada. Table 1 shows the characteristics of our participants. Most of them attended a public high school, were born in Canada and were French speaking. For the parental authority, 80.1% had a college diploma or higher and approximately half had a household income 460,000$ CAN per year. Table 2 shows the AA average daily intake during the 48-h period before biological sample collection and the average daily intake over the last month. Daily AA intakes based on the 2-day food diary were higher than those estimated from the FFQ over the month before biological sampling. Detailed results on foods contributing mostly to acrylamide intake in this teenager group can be found in Normandin et al. 22 Urinary Biomarker Concentrations Concentrations of urinary biomarkers are shown in Table 3 . The LC-MS/MS method was sensitive enough to detect CP, NACP, NACP-S and GAMA3 in almost all urine samples. AA was detectable in 20% of samples, GA in 2.6% and GAMA2 was not detected in any sample. The main metabolites detected were NACP and NACP-S with respective geometric mean concentrations of 81.7 and 39.7 mg/l (31.2 and 14.2 mmol/mol creatinine). Values ranged from 12.0 to 1100.0 mg/l (8.5-354.1 mmol/mol creatinine) for NACP and from 11.0 to 690.0 mg/l (4.8-207.9 mg/g creatinine) for NACP-S. Other metabolite concentrations were in decreasing order: GAMA34CPEAAEGA.
RESULTS
Characteristics of Teenagers
Acrylamide Intake
Hemoglobin Adducts with AA and GA Concentrations of AAVal and GAVal adducts are presented in Table 3 . These two adducts were detected in blood samples from all participants in similar concentrations. The geometric mean concentration for AAVal was 45.4 pmol/g globin with a range of 20.7-113.5 pmol/g globin. Mean concentration for GAVal was 45.6 pmol/g globin with a range of 12.4-132.7 pmol/g globin.
Secondary Smoke Exposure
The distribution of urinary cotinine concentrations (in ng/ml) is shown in Table 3 . Cotinine was detected in 67% of urine samples. Among the 195 participants who provided a urine sample, 125 had no secondary smoke exposure (o6 ng/ml), 56 had a low exposure (Z6 and o30 ng/ml) and 14 had a relatively high exposure (Z30 ng/ml).
Correlation between Biomarkers of Exposure Statistically significant correlations were noted among biomarkers of exposure to AA. The strongest significant correlation was between NACP and NACP-S in urine (r ¼ 0.840; Po0.0001). AAVal and GAVal adducts were moderately correlated (r ¼ 0.718; Po0.0001). GAMA3, NACP and NACP-S in urine were also significantly correlated with hemoglobin adduct levels of AAVal (Po0.0001) and GAVal (Po0.05).
Correlation between AA Intake and Biomarkers of Exposure The daily AA intake during the 2 days before urine sampling was significantly correlated (Po0.05) with the urinary metabolites CP, NACP, NACP-S and GAMA3, but not with hemoglobin adducts (AAVal and GAVal), whereas the mean AA daily intake during the month before blood sampling was significantly correlated (Po0.001) with NACP, NACP-S, GAMA3, AAVal and GAVal, but not with CP (Table 4) .
Multivariate Analyses of Associations between Dietary AA Intake and Biomarkers of Exposure to AA Multivariate linear regression analyses of the association between dietary AA intake (based on the 2-day food diary) and urinary biomarkers of exposure to AA were conducted. Among potentially confounding factors identified in bivariate analyses, only age and parental education level were significantly associated with the sum of urinary NACP and NACP-S concentrations (Po0.20). However, none was confounding when included in the multivariate models. Urinary creatinine concentration was forced in the model and was significantly associated with the sum of NACP and NACP-S (Po0.0001). In the final model, the b-coefficient of the relation between AA intake during the 2 days before the biological sampling (log mg/kg bw/day) and the sum of NACP and NACP-S urinary concentrations (log mmol/mol creat.) was 2.8 Â 10 À 4 (95% CI: 1.9 Â 10 À 4 -3.8 Â 10
; Po0.001). The adjusted R 2 of the model was 0.4124.
Multivariate linear regression analyses of the association between dietary AA intake (based on the FFQ over the month preceding sampling) and hemoglobin adducts (sum of AAVal and GAVal in pmol/g globin) were also performed as shown in Table 5 . A statistically significant association was found between average AA daily intake during the month before blood sampling and the sum of hemoglobin adducts (Po0.001). Low (Po0.0371) and high (Po0.0014) exposure to second-hand smoke was also related to hemoglobin adduct levels. No other confounding factor was included in the model.
DISCUSSION
This biomonitoring study is the first to use several urinary biomarkers and blood biomarkers (hemoglobin adducts) to assess AA exposure in a large group of teenagers, a population who can be considered at risk of high AA exposure. Urinary biomarker concentrations were positively associated with the estimated AA intake during the 2 days before urine collection. Hemoglobin adduct levels were not only associated with AA intake during the month before blood collection but also with low and high exposure to second-hand smoke, as indicated by urinary cotinine levels.
The most abundant urinary metabolites were NACP and NACP-S. Although these metabolites seem to be the most useful for biological monitoring of short term AA exposure, they lack specificity as they are also metabolites of acrylonitrile. 31 GAMA3, a metabolite specific to AA, was detected in 100% of samples, but in lower concentrations than NACP and NACP-S. The other metabolites (GAMA2, GA) do not appear really useful for biomonitoring because of their low detection rate in urine. AAVal and GAVal were detected in all blood samples and their levels were similar, confirming their interest for the biological monitoring of AA exposure, especially as levels of these hemoglobin adducts may reflect those of AA-derived carcinogenic DNA adducts. 31 Methodological validation in our study strengthens the reliability of biomarker measurements in our participants. Interlaboratory comparisons revealed strong correlations between metabolite concentrations measured in both laboratories. However, biases could have been lowered if both laboratories had used the same internal standards and the same standard sources considering the lack of certified reference materials to validate them.
Few studies have assessed AA exposure in teenagers using blood or urinary biomarkers. To our knowledge, only Hartmann et al. 21 measured both urinary and blood biomarkers in the same study among 11 German teenagers aged 11-18 years. Reported median urinary concentrations (and range) of NACP and GAMA3 metabolites were 44 (11-85) mg/l and 15 (4-85) mg/l, respectively. In our study, the median urinary NACP concentration was 77 mg/l with values ranging from 12.0 to 1100.0 mg/l, a distribution of values somewhat higher than the one reported by Hartmann et al. 21 In the latter study, median levels (range) of hemoglobin adducts of AA and GA were 34 (21-71) pmol/g globin and 38 (14-66) pmol/g globin, respectively, whereas corresponding values in our study were 44.5 (20.7-113.5) and 44.8 (12.4-132.7) pmol/g globin, respectively. In the US National Health and Nutrition Examination Survey (NHANES; 2003 , geometric means for AA and GA hemoglobin adduct levels in a group of non-smoking American teenagers (aged 12-19 years) were 52.0 and 50.6 pmol/g globin, respectively, 20 similar to values obtained in our study.
We found a statistically significant association between AAderived hemoglobin adduct level and AA intake obtained with a FFQ in a multivariate model that explained 19.8% of the variance in adduct level (Table 5 ). Other authors have also reported significant associations between AA intake derived from a FFQ and AAVal/GAVal levels. Tran et al. 32 studied the relationship between dietary AA intake and hemoglobin adduct levels in 7000 participants aged Z3 years who participated in the NHANES [2003] [2004] . Dietary AA intake calculated from a FFQ was found to be weakly associated with AAVal and GAVal levels. For example, the models for non-smokers explained 3.5% and 2.1%, respectively, of the variance in AAVal and GAVal (Po0.001). Wilson et al. 33 reported calorie-and age-adjusted Pearson's correlations between AA intake (calculated from a FFQ) and adduct levels of 0.26 for AAVal (95% CI: 0.14-0.36) and 0.31 for In this study, AA intake through food ingestion was found to be a major predictor of biomarker of exposure levels in adolescents. However, in the general population, AA exposure can also be because of cigarette smoke and dermal contact with some user products such as cosmetics and personal care products. 2 In this study, the participants' use of creams known to contain AA or polyacrylamide as non-medicinal ingredients during the month before urine and blood sampling was documented in the lifestyle questionnaire. None of our teenagers used those products. Concerning passive smoke, Vesper et al. 20 reported that it could raise levels of AA and GA hemoglobin adducts. According to their study, a 10% increase in serum cotinine would be associated with an increase of 0.22% and 0.23% of AAVal and GAVal levels, respectively. In our study, passive smoke was significantly associated with hemoglobin adduct levels, but not with urinary biomarker concentrations. Therefore, diet did not appear to be the only source of internal exposure to AA in our non-smoking population.
It was shown in our study that blood biomarker levels (AAVal and GAVal hemoglobin adducts) were more associated with intake estimates derived from the FFQ than from the 2-day diary (contrary to urinary biomarkers). As mentioned in Normandin et al., 22 distribution of daily intakes of acrylamide from the different food items was lower using the FFQ as compared with the 2-day food diary and this may explain the differences. Although the use of a food diary is more precise, it documents intake over a shorter exposure period than the FFQ. Nonetheless, as mentioned in Normandin et al., 22 the same food items were documented with the FFQ and the food diary, and it was shown that the average contribution of main food groups to total daily acrylamide intake was quite similar when using the FFQ as compared with the 2-day diary. Ideally, a controlled study would have led to more precise estimations of daily acrylamide intakes.
It is possible that acrylamide exposure in our teenager group estimated from biological measurements, acrylamide concentration in foods and questionnaire-based food consumption rates were underestimated compared with those of the entire Montreal population, and hence that our sample was not representative of all Montreal teenagers. The goal of the recruitment strategy used in our study was to maximize the number of teenagers recruited. However, there is a probable selection bias because of the low participation rate (o5%). Individuals with a high education level or with an income 460,000$ per year were overrepresented in our population sample. It is known that these socioeconomic characteristics are associated with better food habits and lifestyle. People with a lower income or who are less educated, who were underrepresented in our study, are more inclined to consume high-fat or high-carbohydrate foods (including potato chips and French fries). 34 Nonetheless, AA-derived hemoglobin adducts were detected in all participants in levels comparable to those determined in Americans of the same age group.
Epidemiologic studies investigating the relationship between dietary exposure to AA and carcinogenic risk have not provided conclusive evidence of increased risk at any site. 35 On the other hand, biomonitoring equivalents (BEs) corresponding to cancer risk-specific doses have been calculated for AAVal and GAVal adducts by integrating animal bioassay data and pharmacokinetic modeling: BE values of 1.3 and 0.4 pmol/g globin were estimated for a 1 Â 10 À 4 cancer risk. 36 Median levels documented in this study for AAVal and GAVal adducts exceed the corresponding BE values by factors of 34 and 111, respectively. A major uncertainty surrounding BE values is the assumption of low-dose linearity for cancer response to AA exposure. New rodent bioassays have revealed tumors in multiple organs from both sexes in rats and mice exposed chronically to AA. 37 In conjunction with previous mechanistic data, these results strongly support that AA is a genotoxic carcinogen as a result of metabolic activation to glycidamide. These new bioassay data, together with physiologically based pharmacokinetic/toxicodynamic models, should provide more realistic cancer risk estimates from dietary AA exposure.
In summary, we found that in this group of Canadian teenagers, AA intake during the 2 days before biological measurements was a significant predictor of urinary metabolite concentrations, whereas AA intake during prior month was predictive of hemoglobin adducts levels. Multivariate linear regression analysis also revealed that passive smoke exposure contributed to AA exposure in our participants. AA exposure as documented from urinary biomarkers was somewhat higher than the range of values reported in a group of German teenagers. On the other hand, hemoglobin adduct levels were similar to those of Americans of the same age group. Exceedance of BE values for cancer risk assessment may indicate the need to reduce exposure in adolescents as well as in the rest of the population. 
